GIOVANNETTI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 2.140
AS - Asia 1.101
EU - Europa 890
SA - Sud America 184
AF - Africa 63
OC - Oceania 12
Totale 4.390
Nazione #
US - Stati Uniti d'America 2.062
SG - Singapore 351
CN - Cina 308
IT - Italia 281
BR - Brasile 149
HK - Hong Kong 141
GB - Regno Unito 99
SE - Svezia 89
VN - Vietnam 87
DE - Germania 77
NL - Olanda 54
FR - Francia 53
AT - Austria 51
CA - Canada 51
BG - Bulgaria 48
FI - Finlandia 42
IN - India 40
JP - Giappone 38
TR - Turchia 31
RU - Federazione Russa 30
SN - Senegal 22
KR - Corea 17
BD - Bangladesh 14
ZA - Sudafrica 13
AU - Australia 12
UA - Ucraina 12
PL - Polonia 11
IQ - Iraq 10
PK - Pakistan 10
BE - Belgio 9
AR - Argentina 8
ES - Italia 8
MX - Messico 8
TW - Taiwan 8
MA - Marocco 7
EC - Ecuador 6
EG - Egitto 6
VE - Venezuela 6
CI - Costa d'Avorio 5
CL - Cile 5
IR - Iran 5
LU - Lussemburgo 5
UZ - Uzbekistan 5
JM - Giamaica 4
NP - Nepal 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
ID - Indonesia 3
IL - Israele 3
JO - Giordania 3
PY - Paraguay 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
CO - Colombia 2
CU - Cuba 2
DK - Danimarca 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
KY - Cayman, isole 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MK - Macedonia 2
MY - Malesia 2
NG - Nigeria 2
PS - Palestinian Territory 2
TH - Thailandia 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BM - Bermuda 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
IE - Irlanda 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
TC - Turks e Caicos 1
TZ - Tanzania 1
Totale 4.390
Città #
Ashburn 238
Singapore 210
Woodbridge 177
Fairfield 140
Hong Kong 139
Dallas 137
Chandler 124
Santa Clara 121
San Jose 116
Ann Arbor 115
Houston 114
Serra 71
Shanghai 68
Beijing 55
Seattle 54
New York 53
London 51
Wilmington 49
Sofia 48
Vienna 47
Cambridge 46
Los Angeles 43
Boardman 39
Pisa 33
Ho Chi Minh City 27
Munich 27
Princeton 25
Tokyo 25
Dakar 22
Lauterbourg 22
Amsterdam 19
Lawrence 19
Izmir 18
Redwood City 18
São Paulo 17
Hanoi 16
Medford 16
Frankfurt am Main 15
Helsinki 15
Ottawa 15
Redondo Beach 15
Dearborn 13
Turku 13
Washington 13
Florence 12
Hefei 12
Nanjing 11
Des Moines 10
Rome 10
Toronto 10
Council Bluffs 9
Lucca 9
Orem 9
Buffalo 8
Hyderabad 8
Katwijk 8
Manchester 8
Brussels 7
Denver 7
Dong Ket 7
Guangzhou 7
Istanbul 7
Johannesburg 7
Montreal 7
Nuremberg 7
Pittsburgh 7
Taipei 7
Utrecht 7
Belo Horizonte 6
Chicago 6
Hamilton 6
Livorno 6
Marseille 6
Mumbai 6
Ogden 6
Pistoia 6
Poplar 6
San Diego 6
Seoul 6
Talence 6
Abidjan 5
Bologna 5
Grafing 5
Mexico City 5
Wuhan 5
Baghdad 4
Chennai 4
Da Nang 4
Kunming 4
Lund 4
Madrid 4
Phoenix 4
Piombino 4
Quanzhou 4
Seodaemun-gu 4
Shenyang 4
Stockholm 4
Tashkent 4
Atlanta 3
Baku 3
Totale 3.014
Nome #
GLUT1 and LOX inhibitors as perspective anticancer agents tackling glucose avidity and ECM remodeling in tumors 270
Sonde diagnostiche per evidenziare all’infrarosso cellule e tessuti affetti da condizioni patologiche o metaboliche 232
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 226
Diagnostic probes to detect cells and tissues afflicted with a pathological or metabolic condition by means of infrared spectroscopy 211
Blood platelet RNA yields a new diagnostic prospective for accurate detection and staging of pancreatic ductal adenocarcinoma 196
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer 191
Role of CYB5A in pancreatic cancer prognosis and autophagy modulation. 168
Array-based comparative genomic hybridization analysis to identify prognostic markers for resected pancreatic cancer. 167
The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies 166
Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. 166
The MEK1/2 inhibitor pimasertib enhances gemcitabine efficacy-letter 164
A specific inhibitor of lactate dehydrogenase overcame the resistance toward gemcitabine in hypoxic mesothelioma cells, and modulated the expression of the human equilibrative transporter-1 163
The biology of regulatory pathways of miRNAs, mRNAs and proteins unravels a specific -omics network in tumor-educated platelets from pancreatic cancer patients 163
Abstract 3082: Targeting hypoxic pancreatic cancer cells with glucose conjugated lactate dehydrogenase inhibitor NHI-Glc-2 159
Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing 158
MET as a potential target for the treatment of upper gastrointestinal cancers: characterization of novel c-Met inhibitors from bench to bedside. 157
Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinoma. 152
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds 147
Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study 144
Genetic variation: effect on prostate cancer 133
null 104
The Current Role of Single-Site Robotic Approach in Liver Resection: A Systematic Review 98
Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC) 88
Delayed gastric emptying after pylorus‐preserving pancreatoduodenectomy: Comparison between traditional open surgery and full‐robotic approach with da Vinci Xi 86
The effect of lactate dehydrogenase-A inhibition on intracellular nucleotides and mitochondrial respiration in pancreatic cancer cells 82
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target 79
Prognostic value of microRNA-21 in intra- and extrahepatic cholangiocarcinoma after radical resection: cohort study 77
Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma 68
Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma 66
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers 60
Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer 55
Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism 49
Lactate dehydrogenase A inhibition by small molecular entities: steps in the right direction 22
Totale 4.467
Categoria #
all - tutte 12.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.252


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 0 34
2021/2022300 13 6 11 19 36 42 25 41 10 9 18 70
2022/2023461 34 98 40 27 66 51 6 35 65 4 19 16
2023/2024273 12 16 43 6 30 65 12 7 3 13 28 38
2024/2025991 7 35 23 54 77 110 79 34 71 116 126 259
2025/20261.246 106 179 151 116 142 97 154 58 77 126 32 8
Totale 4.467